Expeditors Announces Semi-Annual Cash Dividend of $0.42
Nov 08, 2017 13:30 pm UTC| Business
SEATTLE, Nov. 08, 2017 -- Expeditors International of Washington, Inc. (NASDAQ: EXPD), today announced that on November 7, 2017, its Board of Directors declared a semi-annual cash dividend of $0.42 per share, payable on...
Nov 08, 2017 13:30 pm UTC| Business
RA’ANANA, Israel and NEW YORK, Nov. 08, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on...
EyeGate Completes Enrollment in Phase 2b Clinical Trial of EGP-437 for Cataract Surgery
Nov 08, 2017 13:30 pm UTC| Business
WALTHAM, Mass., Nov. 08, 2017 -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two platform technologies for treating diseases and...
Think Labs and ePlay’s Mobovivo Partner on Bitcoin-Compatible Sports Games
Nov 08, 2017 13:27 pm UTC| Business
CALGARY, Alberta, Nov. 08, 2017 -- ePlay Digital Inc. (CSE:EPY), today announces that its subsidiary, Mobovivo, has signed a letter of intent to advise, market, and develop a blockchain utility token for sports games in...
Nov 08, 2017 13:20 pm UTC| Business
NEW YORK, Nov. 08, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Carrizo Oil Gas,...
Alpha Pro Tech, Ltd. Announces Financial Results for the Third Quarter
Nov 08, 2017 13:15 pm UTC| Business
Revenue for the third quarter of 2017 increased 2.3% to $12.0 million, compared to $11.8 million in the third quarter of 2016 Gross margin for the third quarter of 2017 increased to 39.1%, up from 38.3% in the third...
Arbor Realty Trust, Inc. Announces the Pricing of $125 million Convertible Senior Notes due 2020
Nov 08, 2017 13:15 pm UTC| Business
UNIONDALE, N.Y., Nov. 08, 2017 -- Arbor Realty Trust, Inc. (the “Company”) (NYSE:ABR) today announced the pricing of its previously announced underwritten public offering of $125 million aggregate principal amount of...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update